Published in PLoS One on May 03, 2013
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception (2014) 1.15
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod (2014) 0.98
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner. J Biol Chem (2014) 0.78
Bridging progestogens in pregnancy and pregnancy prevention. Endocr Connect (2015) 0.77
Gonadal function and reproductive health in women with human immunodeficiency virus infection. Endocrinol Metab Clin North Am (2014) 0.75
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. J Acquir Immune Defic Syndr (2016) 0.75
Coexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque. PLoS One (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
A Wilcoxon-type test for trend. Stat Med (1985) 13.22
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol (1993) 4.16
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol (2000) 3.33
Sex hormones and the immune response in humans. Hum Reprod Update (2005) 3.13
Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev (2005) 3.01
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol (1995) 2.88
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med (1997) 2.56
Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis (2004) 2.47
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol (2003) 2.23
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest (2003) 2.21
Dual HIV-1 infection associated with rapid disease progression. Lancet (2004) 2.17
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol (2007) 2.17
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst (2005) 2.10
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis (2004) 2.03
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.00
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev (2009) 1.95
The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids (2005) 1.83
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology (2013) 1.81
The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS (2008) 1.77
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception (2007) 1.72
Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem (2003) 1.67
Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med (1996) 1.63
Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol (2000) 1.61
Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J Virol (2008) 1.53
Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci (2006) 1.48
The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med (1999) 1.43
Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41
Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab (2003) 1.38
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol (1983) 1.36
Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology (2006) 1.34
The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS (2004) 1.32
HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem (2002) 1.31
Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol (2000) 1.30
HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol (2008) 1.29
Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A (2002) 1.27
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS (2012) 1.26
Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol (2006) 1.24
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20
Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS (2009) 1.18
Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis (2000) 1.18
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology (2011) 1.17
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem (2000) 1.15
The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ (2002) 1.15
Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology (1995) 1.14
HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology (2002) 1.14
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol (2011) 1.13
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids (2011) 1.13
HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS (2009) 1.12
Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol (1999) 1.12
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception (2007) 1.09
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol Cell Endocrinol (2008) 1.09
Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol Cell Endocrinol (2005) 1.08
Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci U S A (1998) 1.08
Hormonal contraception and HIV: an unanswered question. Lancet Infect Dis (2011) 1.07
Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J Immunol (2000) 1.06
Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. J Acquir Immune Defic Syndr (2011) 1.06
HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS (2008) 1.04
A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes. Apoptosis (1997) 1.04
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. J Virol (2009) 1.03
HIV-1 induced bystander apoptosis. Viruses (2012) 1.01
A radioimmunoassay for serum medroxyprogesterone acetate. J Steroid Biochem (1978) 0.99
Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers. AIDS Res Hum Retroviruses (2007) 0.99
Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J Med Primatol (2007) 0.98
Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism. Cell Death Differ (2005) 0.98
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death Differ (2006) 0.97
The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol (2001) 0.97
Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord (2002) 0.97
Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother (2003) 0.96
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One (2010) 0.96
Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med (1998) 0.95
The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem (2003) 0.93
Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration. Steroids (1975) 0.93
Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem (2012) 0.92
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells. AIDS (2010) 0.92
Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest. J Virol (2000) 0.91
Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly. Contraception (1975) 0.91
Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection. J Immunol (2012) 0.91
Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis (2012) 0.91
Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol (2009) 0.90
Retracted Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes. J Biol Chem (2006) 0.89
Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera). Contraception (1974) 0.88
Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells. Mol Cell Endocrinol (2004) 0.86
Delineation of the signaling pathways involved in glucocorticoid-induced and spontaneous apoptosis of rat thymocytes. Endocrinology (2000) 0.85
Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Database Syst Rev (2006) 0.85
High prevalent and incident HIV-1 and herpes simplex virus 2 infection among male migrant and non-migrant sugar farm workers in Zambia. Sex Transm Infect (2011) 0.84
Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis. Arch Virol (2010) 0.83
Aldosterone synthesis and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Sci (2006) 0.83
Not all progestins are the same: implications for usage. Trends Pharmacol Sci (2004) 0.82
Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil Steril (2000) 0.82
Testosterone exerts antiapoptotic effects against H2O2 in C2C12 skeletal muscle cells through the apoptotic intrinsic pathway. J Endocrinol (2012) 0.82
The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis. Infect Immun (2013) 0.82
Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone. Contraception (1979) 0.81
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids (2011) 1.13
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol Cell Endocrinol (2008) 1.09
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception (2011) 1.04
Genomic and nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid receptor signaling pathways. Mol Endocrinol (2009) 0.91
Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment. Biochemistry (2010) 0.88
Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model. PLoS One (2013) 0.87
Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol Cell Endocrinol (2010) 0.83
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. Am J Reprod Immunol (2014) 0.83
Differential nuclear localisation and promoter occupancy play a role in glucocorticoid receptor ligand-specific transcriptional responses. Steroids (2011) 0.81
Microbiome: Restoring healthy growth in infants. Nat Rev Microbiol (2016) 0.79
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy. Biochem Biophys Res Commun (2013) 0.79
Non-coding RNA: RNA stability control by Pol II. Nat Rev Mol Cell Biol (2013) 0.78
Autophagy: STAT3 maintains order. Nat Rev Mol Cell Biol (2012) 0.78
Bacterial toxins: A 'pain-relieving' toxin. Nat Rev Microbiol (2014) 0.78
Cell death: balance through a bivalent regulator. Nat Rev Mol Cell Biol (2013) 0.78
Endocytosis. A new gateway into cells. Nat Rev Mol Cell Biol (2015) 0.77
Cell signalling: budding GPCRs. Nat Rev Mol Cell Biol (2014) 0.76
Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation. J Biol Chem (2014) 0.76
RNA interference: nuclear Dicer makes the cut. Nat Rev Mol Cell Biol (2014) 0.76
Cell signalling: hedgehog puts a damper on autophagy. Nat Rev Mol Cell Biol (2012) 0.76
Glucocorticoid receptor concentration and the ability to dimerize influence nuclear translocation and distribution. Steroids (2012) 0.76
Chromatin: Defining heterochromatin. Nat Rev Mol Cell Biol (2012) 0.76
DNA damage: limiting 53BP1. Nat Rev Mol Cell Biol (2013) 0.76
Meiosis: A kinesin on foreign tracks. Nat Rev Mol Cell Biol (2013) 0.76
Bacterial physiology: FtsZ and FtsA find the right place. Nat Rev Microbiol (2014) 0.76
Bacterial genetics: Metalloregulatory riboswitches. Nat Rev Microbiol (2015) 0.76
Calcium: an ion channel for cilia. Nat Rev Mol Cell Biol (2013) 0.75
Biofilms: The T3SS translocon in biofilm formation. Nat Rev Microbiol (2014) 0.75
Antimicrobials: Pump it out. Nat Rev Microbiol (2016) 0.75
Bacterial genomics: Finding the connection. Nat Rev Microbiol (2016) 0.75
Transcription: a mitochondrial switch between transcription and replication. Nat Rev Mol Cell Biol (2015) 0.75
Fungal pathogenesis: escaping elimination. Nat Rev Microbiol (2013) 0.75
Cell signalling: Double duty for Dishevelled. Nat Rev Mol Cell Biol (2015) 0.75
Structural biology: Expanding the pilus family. Nat Rev Microbiol (2016) 0.75
Cytoskeleton: Remodelling the FtsZ network. Nat Rev Mol Cell Biol (2014) 0.75
Development: Honey, I shrunk the nucleus. Nat Rev Mol Cell Biol (2014) 0.75
Viral infection: Marburg targets the host oxidative response. Nat Rev Microbiol (2014) 0.75
Microscopy: Advancing imaging. Nat Rev Mol Cell Biol (2014) 0.75
Cell signalling: Linking JNK and Hippo signalling. Nat Rev Mol Cell Biol (2013) 0.75
Bacterial pathogenesis: unattractive S. Typhi. Nat Rev Microbiol (2014) 0.75
Bacterial pathogenesis: Pneumococci find a sugar daddy in influenza. Nat Rev Microbiol (2014) 0.75
Cell division: Ciliary membrane inheritance directs ciliogenesis. Nat Rev Mol Cell Biol (2013) 0.75
Bacterial physiology: Salmonella get attached. Nat Rev Microbiol (2016) 0.75
Bacterial pathogenesis: Staphylococcus slips through the net. Nat Rev Microbiol (2013) 0.75
Bacterial physiology: remodelling the FtsZ network. Nat Rev Microbiol (2013) 0.75
Bacterial physiology: When things turn sour for Helicobacter. Nat Rev Microbiol (2017) 0.75
Microbiome: Salmonella breathe out Clostridia. Nat Rev Microbiol (2016) 0.75
Antifungals: Uncovering new drugs and targets. Nat Rev Microbiol (2016) 0.75
Cell signalling: a new Hippo pathway component. Nat Rev Mol Cell Biol (2013) 0.75
Parasite evolution: Adding a piece to the puzzle. Nat Rev Microbiol (2017) 0.75
Archaeal genomics: Divergent methanogenic archaea. Nat Rev Microbiol (2016) 0.75
Viral infection: Dengue as mitochondrial landscapers. Nat Rev Microbiol (2016) 0.75
Parasite biology: A tripartite virulence complex in Toxoplasma. Nat Rev Microbiol (2014) 0.75
Bacterial pathogenicity: Phytoplasma converts plants into zombies. Nat Rev Microbiol (2014) 0.75
Microbiome: Baby steps towards the microbiome. Nat Rev Microbiol (2016) 0.75
Bacterial physiology: Persisters running out of energy. Nat Rev Microbiol (2017) 0.75
Virus Infection: HIV-1 weighs up risks and benefits. Nat Rev Microbiol (2016) 0.75
Chromatin: Limiting the DDR. Nat Rev Mol Cell Biol (2013) 0.75
Bacterial pathogenesis: First aid kit for cholera. Nat Rev Microbiol (2014) 0.75
Metabolism: Restoring brown fat commitment. Nat Rev Mol Cell Biol (2016) 0.75
Systems biology: 'Cache-ing' in on PAS domains. Nat Rev Microbiol (2016) 0.75
Bacterial toxins: A true competitor. Nat Rev Microbiol (2016) 0.75
Bacterial pathogenesis: An interspecies role for SpA. Nat Rev Microbiol (2016) 0.75
Antimicrobials: Tapping into our own resources. Nat Rev Microbiol (2016) 0.75
Bacterial physiology: Persisters are under the pump. Nat Rev Microbiol (2016) 0.75
Fungal biology: A key regulator of secondary metabolites. Nat Rev Microbiol (2016) 0.75
Bacterial pathogenesis: modulating host metabolism. Nat Rev Microbiol (2014) 0.75
Bacterial pathogenesis: Getting all tangled up. Nat Rev Microbiol (2016) 0.75
Organelle dynamics. KIF7 organizes cilia. Nat Rev Mol Cell Biol (2014) 0.75
Bacterial pathogenesis: Spirochete spreading. Nat Rev Microbiol (2016) 0.75
Cell signalling: A new Hippo pathway component. Nat Rev Mol Cell Biol (2013) 0.75
Microbiome: Getting organized early in life. Nat Rev Microbiol (2017) 0.75
Marine microbiology: When a relationship turns ugly. Nat Rev Microbiol (2016) 0.75
Bacterial pathogenesis: Bacterial effectors skip a few steps. Nat Rev Microbiol (2016) 0.75
Bacterial pathogenesis: Copycat Burkholderia make a move. Nat Rev Microbiol (2015) 0.75
Bacterial pathogenesis: A deadly chain of events. Nat Rev Microbiol (2017) 0.75
Bacterial toxins: TcdB aims for Frizzled. Nat Rev Microbiol (2016) 0.75
Protein degradation: An alternative route for mitochondrial quality control. Nat Rev Mol Cell Biol (2014) 0.75
Microbiome: Complexity at the sub-genus level. Nat Rev Microbiol (2016) 0.75
Cytoskeleton: Formins induce nuclear actin assembly. Nat Rev Mol Cell Biol (2013) 0.75
Structural biology: activating and guiding Cas9. Nat Rev Microbiol (2014) 0.75
Viral infection: Moving and splicing M1 mRNA. Nat Rev Microbiol (2016) 0.75
Viral infection: The language of phages. Nat Rev Microbiol (2017) 0.75
Viral infection: Rabies virus causes stress. Nat Rev Microbiol (2016) 0.75
Microbiome: More fibre a day keeps the pathogens away. Nat Rev Microbiol (2016) 0.75
Antimicrobials: Putting antibiotic action into context. Nat Rev Microbiol (2016) 0.75
Endocytosis: Bend it like galectin 3. Nat Rev Mol Cell Biol (2014) 0.75
Mechanotransduction: VE-cadherin lets it flow. Nat Rev Mol Cell Biol (2015) 0.75
Microbiome: Weight loss without the yo-yo effect. Nat Rev Microbiol (2016) 0.75
Cell cycle: regulating chromosome segregation. Nat Rev Mol Cell Biol (2014) 0.75
Parasite development: Plasmodium breaks the linkage. Nat Rev Microbiol (2017) 0.75
Parasite biology: an anchor for Plasmodium invasion. Nat Rev Microbiol (2015) 0.75